Fox Chase Cancer Center: Adenocarcinoma trials

The registry lists 10 Adenocarcinoma studies with Fox Chase Cancer Center as lead sponsor. 2 are open to participants now and 3 have results posted.

Phase 1 6Phase 2 2No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Adaptive Radiation Boost for Rectal CancerRecruitingNCT07221058Phase 1
• Adaptive Radiation Therapy for Men With Intermediate- or High-Risk Prostate CancerRecruitingNCT07219303Not applicable
• Quinacrine-Capecitabine Combinatorial Therapy for Advanced Stage Colorectal AdenocarcinomaTerminatedNCT01844076Phase 1/2Results posted
• Chemoembolization Using Irinotecan in Treating Patients With Liver Metastases From Metastatic Colon or Rectal CancerTerminatedNCT01285102Phase 1Results posted
• Bevacizumab and Combination Chemotherapy Before Surgery in Treating Patients With Locally Advanced Esophageal or Stomach CancerCompletedNCT01212822Phase 2Results posted
• Genetic Mutations in Blood and Tissue Samples in Predicting Response to Treatment in Patients With Locally Advanced Rectal Cancer Undergoing ChemoradiationCompletedNCT02132858
• Irinotecan-Eluting Beads in Treating Patients With Refractory Metastatic Colon or Rectal Cancer That Has Spread to the LiverTerminatedNCT02110953Phase 1
• Chemoradiation and Radiosurgery Boost in Treating Patients With Locally Advance Pancreatic Cancer That May or May Not be Removed by SurgeryTerminatedNCT01739439Phase 1
• Adherence to Survivorship Care Guidelines in Health Care Providers for Non-Small Cell Lung Cancer and Colorectal Cancer Survivor CareCompletedNCT01726296Not applicable
• Vaccine Therapy Plus QS21 in Treating Patients With Advanced Pancreatic or Colorectal CancerCompletedNCT00006387Phase 1